Back
Annovis Bio, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
42
ANVS
Annovis Bio, Inc.
Last Price:
$3.68
Seasonality Move:
32.68%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is moderately bearish and ANVS is experiencing selling pressure, which indicates risk of future bearish movement.
Annovis Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.72 | Sell |
| 20-day SMA: | 3.81 | Sell |
| 50-day SMA: | 3.43 | Buy |
| 200-day SMA: | 2.51 | Buy |
| 8-day EMA: | 3.78 | Sell |
| 20-day EMA: | 3.78 | Sell |
| 50-day EMA: | 3.49 | Buy |
| 200-day EMA: | 3.28 | Buy |
Annovis Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.62 | Sell |
| Chaikin Money Flow: | -375619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.58 - 4.32) | Sell |
| Bollinger Bands (100): | (1.92 - 3.74) | Buy |
Annovis Bio, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Annovis Bio, Inc. Stock
Is Annovis Bio, Inc. Stock a Buy?
-
Annovis Bio, Inc. share price is 3.67 while ANVS 8-day simple moving average is 3.72, which is a Sell signal.
-
The stock price of ANVS is 3.67 while Annovis Bio, Inc. 20-day SMA is 3.81, which makes it a Sell.
-
Annovis Bio, Inc. 50-day simple moving average is 3.43 while ANVS share price is 3.67, making it a Buy technically.
-
ANVS stock price is 3.67 and Annovis Bio, Inc. 200-day simple moving average is 2.51, creating a Buy signal.
ANVS Technical Analysis vs Fundamental Analysis
Sell
42
Annovis Bio, Inc. (ANVS)
is a Sell
Is Annovis Bio, Inc. a Buy or a Sell?
-
Annovis Bio, Inc. stock is rated a SellThe current Annovis Bio, Inc. [ANVS] share price is $3.67. The Score for ANVS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Annovis Bio, Inc. Stock Info
Market Cap:
97.3M
Price in USD:
3.67
Share Volume:
397.9K
Annovis Bio, Inc. 52-Week Range
52-Week High:
5.50
52-Week Low:
1.11
Sell
42
Annovis Bio, Inc. (ANVS)
is a Sell
Annovis Bio, Inc. Share Price Forecast
-
What is the Annovis Bio, Inc. stock price today?The Annovis Bio, Inc. stock price is 3.67 USD today.
-
Will ANVS stock go up or go down?Annovis Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Annovis Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Annovis Bio, Inc. is overvalued.
Is Annovis Bio, Inc. Stock a Buy?
-
Annovis Bio, Inc. share price is 3.67 while ANVS 8-day exponential moving average is 3.78, which is a Sell signal.
-
The stock price of ANVS is 3.67 while Annovis Bio, Inc. 20-day EMA is 3.78, which makes it a Sell.
-
Annovis Bio, Inc. 50-day exponential moving average is 3.49 while ANVS share price is 3.67, making it a Buy technically.
-
ANVS stock price is 3.67 and Annovis Bio, Inc. 200-day simple moving average is 3.28, creating a Buy signal.
Fundamental Analysis of Annovis Bio, Inc.
Is Annovis Bio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.02 per share.
Technical Analysis of Annovis Bio, Inc.
Should I short Annovis Bio, Inc. stock?
-
ANVS Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Annovis Bio, Inc. is a Buy
-
Annovis Bio, Inc. Relative Strength Index (RSI) is 48.62, which suggest Annovis Bio, Inc. is oversold
-
The Bollinger Bands (25) for Annovis Bio, Inc. is (3.58 - 4.32), which suggest Annovis Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Annovis Bio, Inc. is (1.92 - 3.74), which suggest Annovis Bio, Inc. is a Buy
* Annovis Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.